Identification of antifungal agents AR-12 and Fosmanogepix as anti-Trypanosoma cruzi drugs through an enhanced fluorogenic β-galactosidase phenotypic screening assay
Mercedes Didier Garnham, Fátima Agüero, Juan Carlos Ramírez, Fernán Agüero, Emir Salas‐Sarduy
This paper develops a fluorogenic β-galactosidase assay to screen antifungal compounds against Trypanosoma cruzi, identifying AR-12 and Fosmanogepix as potential drugs.
ACS Infectious Diseases · Jan 2, 2026Peer-reviewedMicrobiology